Intrexon | XON - Capitalisation Boursière





Capitalisation Boursière Changement Date
Agenus USD 107M 16M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 21.73B 3B 2026-05
Karyopharm Therapeutics USD 956M 821M 2026-05
MacroGenics USD 102M 4M 2025-12
MannKind USD 1.74B 93M 2025-12
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Veracyte USD 2.62B 704M 2026-05
Xencor USD 1.09B 256M 2025-12